Sobi launch Doptelet® (avatrombopag) in Europe ...Middle East

PR Newswire - News
STOCKHOLM, Nov. 4, 2020 /PRNewswire/ -- Sobi™ Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced the commercial launch of Doptelet® (avatrombopag) in Europe, with the United Kingdom as the first country for launch. Doptelet is a thrombopoietin receptor agonist (TPO-RA)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi launch Doptelet® (avatrombopag) in Europe )

Apple Storegoogle play

Also on site :



Latest News